Roundup: U.S. FDA authorizes Novavax COVID-19 vaccine for emergency use in adults

LOS ANGELES, July 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Wednesday issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine in individuals 18 years of age and older.

The Novavax vaccine will be available as two-dose primary series for adults, three weeks apart.